Age-related changes in Polycomb gene regulation disrupt lineage fidelity in intestinal stem cells

  1. Helen M Tauc
  2. Imilce A Rodriguez-Fernandez
  3. Jason A Hackney
  4. Michal Pawlak
  5. Tal Ronnen Oron
  6. Jerome Korzelius
  7. Hagar F Moussa
  8. Subhra Chaudhuri
  9. Zora Modrusan
  10. Bruce A Edgar
  11. Heinrich Jasper  Is a corresponding author
  1. Genentech, Inc, United States
  2. Institute of Hematology and Blood Transfusion, Poland
  3. Buck Institute for Research on Aging, United States
  4. University of Kent, United Kingdom
  5. Vienna BioCenter (VBC), Austria
  6. University of Utah, United States

Abstract

Tissue homeostasis requires long-term lineage fidelity of somatic stem cells. Whether and how age-related changes in somatic stem cells impact the faithful execution of lineage decisions remains largely unknown. Here, we address this question using genome-wide chromatin accessibility and transcriptome analysis as well as single cell RNA-seq to explore stem cell-intrinsic changes in the aging Drosophila intestine. These studies indicate that in stem cells of old flies, promoters of Polycomb (Pc) target genes become differentially accessible, resulting in the increased expression of enteroendocrine (EE) cell specification genes. Consistently, we find age-related changes in the composition of the EE progenitor cell population in aging intestines, as well as a significant increase in the proportion of EE-specified intestinal stem cells (ISCs) and progenitors in aging flies. We further confirm that Pc-mediated chromatin regulation is a critical determinant of EE cell specification in the Drosophila intestine. Pc is required to maintain expression of stem cell genes while ensuring repression of differentiation and specification genes. Our results identify Pc group proteins as central regulators of lineage identity in the intestinal epithelium and highlight the impact of age-related decline in chromatin regulation on tissue homeostasis.

Data availability

Data generated and analysed are included in the manuscript, figures and figure supplements.All sequencing data generated in this study have been deposited in GEO under accession code GSE164317.

Article and author information

Author details

  1. Helen M Tauc

    Immunology Discovery, Genentech, Inc, South San Francisco, United States
    Competing interests
    Helen M Tauc, employee of Genentech Inc.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0694-2387
  2. Imilce A Rodriguez-Fernandez

    Immunology Discovery, Genentech, Inc, South San Francisco, United States
    Competing interests
    Imilce A Rodriguez-Fernandez, employee of Genentech Inc.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5112-4834
  3. Jason A Hackney

    Bioinformatics, Genentech, Inc, South San Francisco, United States
    Competing interests
    Jason A Hackney, employee of Genentech Inc.
  4. Michal Pawlak

    Bioinformatics, Institute of Hematology and Blood Transfusion, Warsaw, Poland
    Competing interests
    No competing interests declared.
  5. Tal Ronnen Oron

    Bioinformatics, Buck Institute for Research on Aging, Novato, United States
    Competing interests
    No competing interests declared.
  6. Jerome Korzelius

    School of Biosciences, University of Kent, Canterbury, United Kingdom
    Competing interests
    No competing interests declared.
  7. Hagar F Moussa

    Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Vienna, Austria
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3463-0126
  8. Subhra Chaudhuri

    Micro Array Lab, Genentech, Inc, South San Francisco, United States
    Competing interests
    Subhra Chaudhuri, employee of Genentech Inc.
  9. Zora Modrusan

    Microchemistry, Proteomics and Lipidomics, Genentech, Inc, South San Francisco, United States
    Competing interests
    Zora Modrusan, employee of Genentech Inc.
  10. Bruce A Edgar

    Department of Oncological Sciences, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3383-2044
  11. Heinrich Jasper

    Immunology Discovery, Genentech, Inc, South San Francisco, United States
    For correspondence
    jasper.heinrich@gene.com
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6014-4343

Funding

EMBO Long-Term Fellowship (ALTF 1516-2011)

  • Jerome Korzelius

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Tauc et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,695
    views
  • 572
    downloads
  • 28
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Helen M Tauc
  2. Imilce A Rodriguez-Fernandez
  3. Jason A Hackney
  4. Michal Pawlak
  5. Tal Ronnen Oron
  6. Jerome Korzelius
  7. Hagar F Moussa
  8. Subhra Chaudhuri
  9. Zora Modrusan
  10. Bruce A Edgar
  11. Heinrich Jasper
(2021)
Age-related changes in Polycomb gene regulation disrupt lineage fidelity in intestinal stem cells
eLife 10:e62250.
https://doi.org/10.7554/eLife.62250

Share this article

https://doi.org/10.7554/eLife.62250

Further reading

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics
    Steven Henikoff, David L Levens
    Insight

    A new method for mapping torsion provides insights into the ways that the genome responds to the torsion generated by RNA polymerase II.

    1. Genetics and Genomics
    2. Microbiology and Infectious Disease
    Nicole Herrmann May, Anh Cao ... Tom Beneke
    Research Advance

    The ability to analyze the function of all genes in a genome is highly desirable, yet challenging in Leishmania due to a repetitive genome, limited DNA repair mechanisms, and lack of RNA interference in most species. While our introduction of a cytosine base editor (CBE) demonstrated potential to overcome these limitations (Engstler and Beneke, 2023), challenges remained, including low transfection efficiency, variable editing rates across species, parasite growth effects, and competition between deleterious and non-deleterious mutations. Here, we present an optimized approach addressing these issues. We identified a T7 RNAP promoter variant ensuring high editing rates across Leishmania species without compromising growth. A revised CBE single-guide RNAs (sgRNAs) scoring system was developed to prioritize STOP codon generation. Additionally, a triple-expression construct was created for stable integration of CBE sgRNA expression cassettes into a Leishmania safe harbor locus using AsCas12a ultra-mediated DNA double-strand breaks, increasing transfection efficiency by ~400-fold to 1 transfectant per 70 transfected cells. Using this improved system for a small-scale proof-of-principle pooled screen, we successfully confirmed the essential and fitness-associated functions of CK1.2, CRK2, CRK3, AUK1/AIRK, TOR1, IFT88, IFT139, IFT140, and RAB5A in Leishmania mexicana, demonstrating a significant improvement over our previous method. Lastly, we show the utility of co-expressing AsCas12a ultra, T7 RNAP, and CBE for hybrid CRISPR gene replacement and base editing within the same cell line. Overall, these improvements will broaden the range of possible gene editing applications in Leishmania species and will enable a variety of loss-of-function screens in the near future.